– Reuters
Related Posts
JP Morgan Maintains Neutral on Lockheed Martin, Lowers Price Target to $481
JP Morgan analyst Seth Seifman maintains Lockheed Martin (NYSE:LMT) with a Neutral and lowers the price target from $495 to…
Maxim Group Initiates Coverage On Acrivon Therapeutics with Buy Rating, Announces Price Target of $24
Maxim Group analyst Michael Okunewitch initiates coverage on Acrivon Therapeutics (NASDAQ:ACRV) with a Buy rating and announces Price Target of…
Dependable Dividend Guide: Top 5 High Growth Dividend Stocks for 2024 and Beyond
Investors seeking a combination of both growth and income from their portfolio have a number of compelling investment categories to…